Grufity logo
Grufity logo

Latest Propel Bio Management, LLC Stock Portfolio

$158Million– No. of Holdings #38

Propel Bio Management, LLC Performance:
2026 Q1: -7.07%YTD: -7.07%2025: 17.61%
Performance for 2026 Q1 is -7.07%, and YTD is -7.07%, and 2025 is 17.61%.

About Propel Bio Management, LLC and 13F Hedge Fund Stock Holdings

On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Propel Bio Management, LLC reported an equity portfolio of $158.7 Millions as of 31 Mar, 2026.

The top stock holdings of Propel Bio Management, LLC are PAGP, ACHV, PHAT. The fund has invested 19% of it's portfolio in PLAINS GP HLDGS L P and 7.2% of portfolio in ACHIEVE LIFE SCIENCES INC.

The fund managers got completely rid off NEKTAR THERAPEUTICS (NKTR), REGENXBIO INC (RGNX) and LENZ THERAPEUTICS INC stocks. They significantly reduced their stock positions in OCULIS HOLDING AG, INVENTIVA SA (IVA) and VIRIDIAN THERAPEUTICS INC (VRDN). Propel Bio Management, LLC opened new stock positions in CORCEPT THERAPEUTICS INC (CORT), VOR BIOPHARMA INC (VOR) and ORCHESTRA BIOMED HLDGS INC. The fund showed a lot of confidence in some stocks as they added substantially to KALARIS THERAPEUTICS INC, DELCATH SYS INC (DCTH) and ABEONA THERAPEUTICS INC (ABEO).
Propel Bio Management, LLC Equity Portfolio Value
Last Reported on: 14 May, 2026

Propel Bio Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Propel Bio Management, LLC made a return of -7.07% in the last quarter. In trailing 12 months, it's portfolio return was 14.76%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
corcept therapeutics inc6,022,010
vor biopharma inc5,587,370
orchestra biomed hldgs inc3,830,720
4d molecular therapeutics in3,581,150
ocular therapeutix inc3,226,120
upstream bio inc3,100,130
aquestive therapeutics inc2,950,600
eyepoint inc2,788,940
New stocks bought by Propel Bio Management, LLC

Additions

Ticker% Inc.
kalaris therapeutics inc603
zevra therapeutics inc343
delcath sys inc123
abeona therapeutics inc60.08
sab biotherapeutics inc55.13
phathom pharmaceuticals inc13.54
Additions to existing portfolio by Propel Bio Management, LLC

Reductions

Ticker% Reduced
oculis holding ag-29.29
inventiva sa-27.53
viridian therapeutics inc-25.61
celldex therapeutics inc new-14.86
compass pathways plc-13.89
kyverna therapeutics inc-3.34
Propel Bio Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
regenxbio inc-1,683,300
nektar therapeutics-3,501,710
lenz therapeutics inc-945,360
aardvark therapeutics inc-609,105
Propel Bio Management, LLC got rid off the above stocks

Sector Distribution

Propel Bio Management, LLC has about 63.1% of it's holdings in Healthcare sector.

  • Healthcare
  • Energy
  • Others
Sector%
Healthcare63.1
Energy19
Others17.8

Market Cap. Distribution

Propel Bio Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • MICRO-CAP
  • MID-CAP
  • UNALLOCATED
Category%
SMALL-CAP30
MICRO-CAP25.8
MID-CAP25.4
UNALLOCATED17.8

Stocks belong to which Index?

About 30.6% of the stocks held by Propel Bio Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others69.4
RUSSELL 200030.6
Top 5 Winners (%)%
ATHA
leonabio inc
32.4 %
oculis holding ag
29.3 %
PAGP
plains gp hldgs l p
23.9 %
IVA
inventiva sa
16.0 %
CLDX
celldex therapeutics inc new
14.7 %
Top 5 Winners ($)$
PAGP
plains gp hldgs l p
5.8 M
oculis holding ag
1.0 M
IVA
inventiva sa
0.7 M
CLDX
celldex therapeutics inc new
0.6 M
ATHA
leonabio inc
0.4 M
Top 5 Losers (%)%
ACHV
achieve life sciences inc
-39.6 %
MIST
milestone pharmaceuticals in
-38.9 %
VRDN
viridian therapeutics inc
-32.7 %
PHAT
phathom pharmaceuticals inc
-31.6 %
kalaris therapeutics inc
-20.5 %
Top 5 Losers ($)$
ACHV
achieve life sciences inc
-7.4 M
PHAT
phathom pharmaceuticals inc
-4.3 M
MIST
milestone pharmaceuticals in
-3.2 M
VRDN
viridian therapeutics inc
-2.9 M
CMPS
compass pathways plc
-1.1 M

Propel Bio Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Propel Bio Management, LLC

Propel Bio Management, LLC has 38 stocks in it's portfolio. About 58.3% of the portfolio is in top 10 stocks. ACHV proved to be the most loss making stock for the portfolio. PAGP was the most profitable stock for Propel Bio Management, LLC last quarter.

Last Reported on: 14 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions